NephRx News

NephRx Corp. Awarded U.S. PATENT for nx002 for treatment of oral mucositis

Kalamazoo, Michigan - November 30, 2011  -  NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in precl .... Read more

NEPHRX CORP. AWARDED U.S. PATENT FOR USE OF NOVEL GROWTH FACTOR PEPTIDE NX002 IN INFLAMMATORY BOWEL DISEASE

Kalamazoo, MI – March 23, 2011 – NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potent .... Read more